Coriell Institute for Medical Research
Request a Quote
Careers
Login
View Cart
Samples
OR
Website
Search Help?
Sample Catalog
|
Custom Services
|
Core Facilities
|
Genomic Data Search
Navigation Header
Biobank
NIGMS
NINDS
NIA
NHGRI
Allen Cell Collection
Rett Syndrome iPSC Collection
Autism Research Resource
HD Community Biorepository
CDC Cell and DNA
NEI
J. Craig Venter Institute
Orphan Disease Center Collection
Phase Clinical Services
All Biobanks
Research
Overview
Meet Our Scientists
Our Faculty
Our Scientific Staff
Camden Cancer Research Center
Epigenetic Therapies SPORE
Core Facilities
Epigenomics
Camden Opioid Research Initiative (CORI)
The Issa & Jelinek Lab
The Jian Huang Lab
The Luke Chen Lab
The Lab
The Team
Publications
The Scheinfeldt Lab
The Shumei Song Lab
The Nora Engel Lab
The Lab
The Team
Publications
Coriell Personalized Medicine Collaborative (CPMC)
Publications
Services
Stem Cells
Core Facilties
Overview
Animal and Xenograft
Bioinformatics and Biostatistics
Cell Imaging
CRISPR Gene Engineering
Flow Cytometry and Cell Sorting
Genomics and Epigenomics
iPSC - Induced Pluripotent Stem Cells
Organoids
Biobanking and Distribution
Biobanking
Biological and Pharmaceutical Storage
Collection Kits
Coriell Marketplace
Research Support Services
Sample Procurement
Cellular and Molecular Analysis
Genomic and Epigenomic Services
Nucleic Acid Isolation and Quality Control
Customized Experimental Design and Research Solutions
Biomarkers
Cell Culture
Research and Development Models
Browse
Stem Cells
Cell Lines
DNA and RNA
Featured Products
FFPE
HMW DNA
Genomic Data Search
Diseases
Rare Diseases
Species
Gene Variants, Mutations
Notable Collections
GRC
REGARDS
Amish Major Affective Disorders
Longevity Research
Search by Catalog ID
Search Help
Ordering
Create Account
Order Online
Ordering FAQ
FAQs/Culture Instructions
Reference Materials
Biobanks
NIGMS Repository
NHGRI Repository
NINDS Repository
NIA Repository
NIST
GeT-RM
Secondary Distribution Policies
MTA Assurance Form
Shipment Policy
Contact Customer Service
Donate
Our Message
Your Impact
Giving FAQs
Make a Donation
About Us
Our History
Meet Our Team
Meet Our Board
Education
Science Fair
Summer Experience
Outreach
Research Program Internship
Press Room
Press Releases
Coriell Blog
Annual Report
Careers
Working at Coriell
Current Openings
Giving
Our Message
Your Support in Action
Giving FAQ
Giving Tuesday
Contact Us
Legal Notice
Login
View Cart
search submit
GM29054
iPSC
from
Fibroblast
Description:
ISOGENIC CONTROL
GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1
SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1; SLC2A1
Affected:
Yes
Sex:
Female
Age:
19
YR
(At Sampling)
Sample Description
Overview
Characterizations
Phenotypic Data
External Links
Culture Protocols
Overview
Repository
NIGMS Human Genetic Cell Repository
Subcollection
Gene-Edited hiPSC
Heritable Diseases
PIGI Consented Sample
Protocols
Protocol PDF
Biopsy Source
Skin
Cell Type
Stem cell
Cell Subtype
Induced pluripotent stem cell
Transformant
Reprogrammed (Retroviral)
Sample Source
iPSC from Fibroblast
Race
White
Ethnicity
Not Hispanic/Latino
Ethnicity
Irish, English, German, Dutch
Country of Origin
GERMANY
Family Member
1
Family History
N
Relation to Proband
proband
ISCN
46,XX[20]
Species
Homo
sapiens
Common Name
Human
Remarks
See Phenotypic Data tab. This line is the isogenic control for the patient-derived iPSC line GM27896; parental fibroblast GM27897. Researchers purchasing hiPSCs from the NIGMS Repository are responsible for any limited use label licenses (LULLs) applicable to the cell line purchased. The applicable LULL to this line is
iPS Academia, Japan Inc.
.
Characterizations
Passage Frozen
36
Induced Pluripotent Stem Cell
After mutation correction with CRISPR/Cas9 the cell line was recovered and expanded. The expanded line was evaluated for viability surface antigen expression and alkaline phosphatase activity. Pluripotency was assessed via embryoid body (EB) formation. Steady-state mRNA expression patterns of undifferentiated iPSC and EBs were determined via real-time PCR. Characterization data are included in the
Certificate of Analysis.
Phenotypic Data
Demographic Data
Relation to Proband
proband
Age at Sampling
19 YR
Sex
Female
Age at Diagnosis(If not a control)
10 YR
Hispanic or Latino/Not Hispanic or Latino
Not Hispanic/Latino
Racial Category
White
Country
GERMANY
Data Elements
Clinical Element Type: General NIGMS Catalog Remarks
(Baseline)
Mutation Information
Gene, variant, consequence, and exon number:
C.1454 C>T (P.PRO485LEU) PATHOGENIC MUTATION IN SLC2A1
Zygosity:
Heterozygous
Age of Symptom Onset and Age at Diagnosis
Age at Diagnosis:
10
In Utero History Information
Birth History Information
Caesarian section
Dysmorphic Features
Neurological Symptoms
Ataxia
Hypotonia
Seizures
White matter issues
Additional Information:
ENCEPHALOPATHY WITH OCULAR VERSIONS IN ADDITION TO BEHAVIORAL ARREST; MILD PERIVENTRICULAR WHITE MATTER VOLUME LOSS; GLIOSIS; HAND SPASTICITY; MILD HYPOTONICITY IN LIMBS; ADDUCTOR SPASTICITY IN LOWER EXTREMITIES; FINGER-TAPPING; INCREASED PAIN TOLERANCE; BABINSKI SIGNS
Optical and Audiological Symptoms
Additional Information:
OCULOMOTOR DYSPRAXIA
Musculoskeletal Symptoms
Additional Information:
MILD SHORTENING OF ACHILLES TENDON BILATERALLY
Developmental Milestones
Additional Information:
MOTOR DISABLED
Gastrointestinal Symptoms
Constipation
Genitourinary Symptoms
Respiratory and Cardiovascular Symptoms
Cognitive and Behavioral Symptoms
Happy personality
Intellectual Disability:
Moderate
Additional Information:
DYSARTHRIC SPEECH
Additional Information
Testing Performed
Neurological Testing:
VIDEO EEG DOCUMENTED FREQUENT BURSTS OF SPIKE-AND-SLOW-WAVE AT 3 HZ; BRAIN PET SCAN ILLUSTRATES DIMINISHED CORTICAL UPTAKE, DIMINISHED THALAMIC UPTAKE, INCREASED UPTAKE IN BASAL GANGLIA, AND DIMINISHED CEREBELLAR UPTAKE WITHOUT FOCALITY; BRAIN MRI COMPATIBLE WITH MILD PERIVENTRICULAR WHITE MATTER VOLUME LOSS AND GLIOSIS
Uncategorized Testing:
LUMBAR PUNCTURE REVEALED LOW CSF GLUCOSE
Treatments and Assistive Devices
Occupational therapy
Physical therapy
Speech therapy
Additional Testing:
KETOGENIC DIET; ATKINS DIET; VAGAL NERVE STIMULATOR; TONSILLECTOMY; ADENOIDECTOMY
Medications
ACETAZOLAMIDE; TIAGABINE (ALLERGIC); LAMOTRIGINE (ALLERGIC); POLYCITRA; MULTIVITAMINS; OMEGA 369; VITAMIN DROPS; ETHOSUXIMIDE; LEVETIRACETAM; FELBAMATE; TOPIRAMATE; ZONISAMIDE; VALPROATE; PHENOBARBITAL; MIDAZOLAM
Family History
SISTER SUFFERED FROM STATUS EPILEPTICUS AND HAD COMPLEX FEBRILE SEIZURES; 2 COUSINS HAD SEIZURES, 1 OF WHICH SUFFERS FROM COMPLEX PARTIAL EPILEPSY
Remarks
See Phenotypic Data tab. This line is the isogenic control for the patient-derived iPSC line GM27896; parental fibroblast GM27897. Researchers purchasing hiPSCs from the NIGMS Repository are responsible for any limited use label licenses (LULLs) applicable to the cell line purchased. The applicable LULL to this line is
iPS Academia, Japan Inc.
.
External Links
Gene Cards
SLC2A1
Gene Ontology
GO:0005215 transporter activity
GO:0005351 sugar porter activity
GO:0005355 glucose transporter activity
GO:0005624 membrane fraction
GO:0008643 carbohydrate transport
GO:0015758 glucose transport
GO:0016021 integral to membrane
NCBI Gene
Gene ID:6513
NCBI GTR
138140 SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1; SLC2A1
606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1
OMIM
138140 SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1; SLC2A1
606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1
Culture Protocols
Passage Frozen
36
Split Ratio
1:8
Temperature
37 C
Percent CO2
5%
Percent O2
AMBIENT
Medium
mTeSR1
Serum
none
Substrate
Matrigel
Supplement
-
Pricing
Commercial/For-profit:
$1,789.00
USD
Academic/Non-profit/Government:
$1,110.00
USD
Add to Cart
How to Order
Ordering Instructions
MTA / Assurance Form
Statement of Research Intent Form
Related Products
Same Subject
GM27896 - Stem cell
GM27897 - Fibroblast
Same Family
3500
Miscellaneous
DNA on Demand
Custom Services